Related Experiment Video
Updated: Jul 11, 2026
Orthotopic Liver Transplantation in Rats
Published on: July 1, 2012
The paediatric liver transplantation program at the Université catholique de Louvain
R Reding1, C Bourdeaux, J Gras
1Paediatric Liver Transplantation Program, Université catholique de Louvain, Saint Luc university Clinics, Brussels, Belgium. reding@chex.ucl.ac.be
Insights
Paediatric liver transplantation has seen significant progress, with living donor transplants improving outcomes and reducing retransplantation. Steroid avoidance may benefit growth, with tacrolimus and basiliximab showing promise.
Area of Science:
- Hepatology
- Pediatric Surgery
- Immunology
Background:
- The Saint-Luc University Clinics Paediatric Liver Transplant Program has performed 667 transplantations over 20 years.
- Pediatric liver transplantation is complex, influenced by multiple surgical and immunological factors.
Purpose of the Study:
- To analyze the impact of surgical and immunological parameters on outcomes after pediatric liver transplantation.
- To evaluate the effect of living related liver transplantation and novel immunosuppression strategies.
Main Methods:
- Retrospective analysis of 667 pediatric liver transplant cases (1984-2003).
- Assessment of surgical learning curve, pre-transplant diagnosis, and primary immunosuppression.
- Evaluation of living related liver transplantation outcomes.
- Pilot study on steroid avoidance and tacrolimus/basiliximab combination therapy.
Main Results:
- Significant learning curve effect observed.
- Pre-transplant diagnosis impacts survival; immunosuppression affects rejection.
- Living related liver transplantation increased access by 74% and improved graft survival.
- Steroid avoidance with tacrolimus/basiliximab appears safe and potentially beneficial for growth.
Conclusions:
- Pediatric liver transplantation outcomes have improved due to advancements and strategies like living donor transplants.
- Steroid avoidance and alternative immunosuppression regimens warrant further investigation.
- Long-term challenges include immunosuppression withdrawal, adolescent transplant care, and atherogenesis risk.
Abstract:
The Paediatric Liver Transplant Program at Saint-Luc University Clinics constitutes a substantial single centre experience, including 667 transplantations performed between March 1984 and April 2003, and the history of this program reflects the tremendous progress in this field since twenty years. Liver transplantation in children constitutes a considerable undertaking and its results depend on multiple, intermingled risk factors. An analysis of the respective impact of several surgical and immunological parameters on patient/graft outcome and allograft rejection after paediatric liver transplantation showed a significant learning curve effect as well as the respective impact of pre-transplant diagnosis on survival and of primary immunosuppression on the rejection incidence. The introduction of living related liver transplantation in 1993 not only permitted to provide access to liver replacement in as many as 74% more candidate recipients, but also resulted in better graft survival and reduced retransplantation rate. The results of a recent pilot study suggest that steroid avoidance is not harmful, and could even be beneficial for paediatric liver recipients, particularly regarding growth, and that combining tacrolimus with basiliximab (anti-CD25 chimeric monoclonal antibody) for steroid substitution appears to constitute a safe alternative in this context. The long-term issues represent the main future challenges in the field, including the possibility of a full rehabilitation through immunosuppression withdrawal and tolerance induction, the development of adolescence transplant medicine, and the risk of early atherogenesis in the adulthood.
